Cristina Rabasco - Publications

Identification of early predictors of clinical remission in primary membranous nephropathy: a post hoc analysis of the STARMEN trial.

Journal: Clinical kidney journal

Published: November 22, 2024

Effect of Immunosuppressive Treatments on Kidney Outcomes After Gross Hematuria-Related Acute Kidney Injury in Older Patients With IgA Nephropathy.

Journal: Kidney international reports

Published: April 06, 2023

Genetic testing in focal segmental glomerulosclerosis: in whom and when?

Journal: Clinical kidney journal

Published: March 09, 2023

Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy.

Journal: Kidney360

Published: December 02, 2022

Oral Anticoagulation in Patients with Chronic Kidney Disease and Non-Valvular Atrial Fibrillation: The FAERC Study.

Journal: Healthcare (Basel, Switzerland)

Published: November 08, 2022

Thrombotic microangiopathy in patients with malignant hypertension.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: May 17, 2022

Kidney Biopsy in Patients with Cancer along the Last Decade: A Multicenter Study.

Journal: Journal of clinical medicine

Published: March 28, 2022

Anti-glomerular Basement Membrane Glomerulonephritis: A Study in Real Life.

Journal: Frontiers in medicine

Published: March 03, 2022

Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy.

Journal: Clinical kidney journal

Published: February 01, 2022

Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: January 27, 2021

The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy.

Journal: Kidney international

Published: August 13, 2020

Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: December 13, 2019